EFG
ORGO icon

Ethos Financial Group’s Organogenesis Holdings ORGO Stock Holding History

Ethos Financial Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.3K Hold
12,987
– – ﹤0.01% 526
2025
Q4 		$67.3K Buy
+12,987
New +$62.9K 0.01% 513

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ethos Financial Group's ORGO Position: Q1 2026 in Review

Ethos Financial Group held its Organogenesis Holdings (ORGO) position steady in Q1 2026 at 12,987 shares worth $67.3K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Ethos Financial Group first reported a position in ORGO in Q4 2025 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Ethos Financial Group held 12,987 shares of Organogenesis Holdings worth $67.3K as of Q1 2026.
  • Ethos Financial Group left its Organogenesis Holdings share count unchanged in Q1 2026.
  • Organogenesis Holdings made up ﹤0.01% of Ethos Financial Group's portfolio in Q1 2026, its #526 holding.
  • Ethos Financial Group first reported a position in Organogenesis Holdings in Q4 2025 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Ethos Financial Group's 13F filing for Q1 2026, filed 5 May 2026.